Harri Niinikoski
Professor, Nutrition in Medicine (Institute of Biomedicine)
hjniin@utu.fi TUCH (phone): +358-2-3130000 ORCID-tunniste: https://orcid.org/0000-0002-7071-918X |
Childhood endocrinology and nutrition; inherited metabolic diseases; neonatal screening; prevention of cardiovascular risk factors.
Professor Harri Niinikoski graduated from the Medical School at the University of Turku
in 1991, where he also specialized in Pediatrics in 2000 and received
subspecialty in Pediatric Endocrinology in 2006. He defended his thesis on prevention
of cardiovascular risk factors in childhood in 1997 (The STRIP study). He did
his post-doc training at the Childhood Nutrition Research Center at the Baylor
School of Medicine, Houston, Texas, in 2001-2003. Subsequently, he worked as a
Senior Clinical Researcher and Clinical Lecturer at the Department of Pediatrics,
University of Turku, and in 2011-2015 as the Head of the Division of Pediatric
Care in Turku University Hospital. From 2015, he has been Professor of Nutrition
in Medicine
Professor Harri Niinikoski’s research interest focus on primary prevention of
cardiovascular disease, and childhood nutrition, endocrinology and metabolism.
Moreover, he has been closely involved in launching the neonatal metabolic
screening program which started in Finland in 2015.
Main research projects are 1) The STRIP study (The Special Turku coronary risk
factor Intervention Project) which started in 1990 and involved 1062 infants
which were randomized into nutrition an intervention or a control group. He is deputy P.I. in STRIP; 2) DIARA2 study which involves 317 children (217 in
Turku, 100 in Oulu) whose mothers were treated with either metformin or insulin
due to gestational diabetes. The children are now thoroughly investigated at 9
years of age; 3) LPI study. Lysinuric protein intolerance (LPI) is a rare
metabolic disease which belongs to the Finnish disease heritage. There are
approx. 50 Finnish patients who are annually studied at the Turku University
Hospital pediatric metabolic outpatient clinic; 4) Congenital
hypothyroidism study. CH has been screened in Finland since 1980, affects
1:2000 newborns and is treated with thyroxine. The outcome of the treatment of
CH is investigated in national CH study which is launched in 2018.
In 2006-2010, Harri Niinikoski worked as a full-time teacher of pediatrics at the
Department of Pediatrics, University of Turku.
- Normaali kasvu (2023) Lastentaudit Niinikoski Harri, Saari Antti
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Nuoruusiän biologinen kehitys ja masennusriski (2023) Nuorten masennus ja interpersonaalinen terapia Karlsson Hasse, Niinikoski Harri
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Nuoruusiän syömishäiriöt (2023) Lastentaudit Ruusunen Anu, Niinikoski Harri
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Plasma calprotectin is extremely high in patients with lysinuric protein intolerance (2023)
- JIMD Reports
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Prediction of pre-diabetes and type 2 diabetes nine years postpartum using serum metabolome in pregnant women with gestational diabetes requiring pharmacological treatment (2023)
- Journal of Diabetes and its Complications
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Ravinto (2023) Lastentaudit Luukkainen Päivi, Niinikoski Harri
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Sairaan lapsen hoito kotona (2023) Lastentaudit Niinikoski Harri, Palmu Sauli
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Tracking of Cardiorespiratory Fitness and Physical Activity from Youth to Young Adulthood: Findings from the Prospective Special Turku Coronary Risk Factor Intervention Project (STRIP) (2023)
- Journal of Pediatrics: X
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Weekday and weekend physical activity patterns and their correlates among young adults (2023)
- Scandinavian Journal of Medicine and Science in Sports
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - What is the role of puberty in the development of islet autoimmunity and progression to type 1 diabetes? (2023)
- European Journal of Epidemiology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )



